News
All news from Vismederi Holding
A new scientific publication from VisMederi has recently been published in Influenza and Other Respiratory Viruses.
A new scientific publication from VisMederi has recently been published in Influenza and Other Respiratory Viruses. The study, “Impact of ABO Blood System on Immunogenicity and Vaccine Efficacy of COVID-19 Booster Vaccination,” analyzed data from 3,066...
VisMederi announces the successful qualification of a standardized, high-throughput Luminescence Serum Bactericidal Assay (L-SBA)
VisMederi announces the successful qualification of a standardized, high-throughput Luminescence Serum Bactericidal Assay (L-SBA) — a key milestone in supporting the evaluation of next-generation Shigella vaccines. This achievement reflects the strength of an...
Bundibugyo ebolavirus: supporting vaccine development for an emerging public health threat
First identified in Uganda in 2007, Bundibugyo ebolavirus is one of the species of the Ebola virus. Although it has historically shown a lower case fatality rate than some other Ebola virus species, typically between 25% and 40%, it remains a serious public health...
VisMederi Expands Its Service Portfolio with End-to-End Sample Kit Management
From kit design and manufacturing to biological sample management and laboratory testing, VisMederi offers a fully integrated solution for clinical trials and research programs worldwide. VisMederi, a company specialized in vaccine evaluation through advanced...
VisMederi and CEVAC Sign Memorandum of Understanding to Strengthen Vaccine Clinical Trial Capabilities in Europe
VisMederi and CEVAC, a Belgian vaccine research center comprising a Clinical Trial Unit and an Immunomonitoring Laboratory, have signed a Memorandum of Understanding (MoU) to strengthen their collaboration in vaccine clinical trials, a core area of expertise for...
VisMederi and KingMylab Sign Strategic Partnership to Strengthen Global Clinical Trial Testing Services for Vaccines and Biologics
VisMederi and KingMylab have announced the signing of a strategic collaboration agreement aimed at strengthening testing and analytical services for vaccine and biologics clinical trials. The partnership combines KingMylab’s expertise in central laboratory...